Status:
COMPLETED
Air Dissection in Percutaneous Radiofrequency Ablation of T1a Renal Cell Carcinoma
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Unrecognized Condition
Eligibility:
All Genders
Brief Summary
The investigators aimed to evaluate the feasibility and safety of using ambient air to protect against thermal injury during RadioFrequency Ablation (RFA) for Renal Cell Carcinoma (RCC) based on data ...
Detailed Description
The incidence of renal cell carcinoma (RCC) has been increasing, particularly among patients \>65 years of age. As older individuals are at higher risk for surgical complications, the use of radiofreq...
Eligibility Criteria
Inclusion
- Patients with Renal Cell Carcinoma (RCC)
- Patients with a single SRM of \<4 cm, confirmed as RCC on biopsy
- RCC status : pT1a
- Eligible patients for an RadioFrequency Ablation (RFA) treatment
Exclusion
- Patients who have already received a RFA treatment for an other tissu or tumor
- Patients who have a bleeding tumor or prior local treatment
Key Trial Info
Start Date :
January 11 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2016
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03395379
Start Date
January 11 2012
End Date
May 15 2016
Last Update
January 10 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.